3 Promising Cancer Immunotherapies to Watch in 2018 — The …Motley FoolBristol-Myers Squibb, Incyte, and Nektar Therapeutics could provide the biggest fireworks next year on the immunotherapy scene. Keith Speights. (TMFFishBiz). Dec 22, 2017 at … Continue reading
|
Piper Jaffray Assumes CRISPR Therapeutics (CRSP) at Overweight
StreetInsider.com Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com’s Dividend Insider Elite. Sign-up for a FREE trial here. Piper Jaffray assumes coverage on CRISPR Therapeutics (NASDAQ: CRSP) with a … CRISPR Therapeutics AG (:CRSP) Insider Watch on The StockThe Herald |
|
Immunotherapy targets identified using new technology
Scope (blog) ‘The whole foundation of immunotherapy depends on immune cells recognizing specific antigens on tumor cells. That’s the basis of the actual killing event — where the rubber hits the road,’ Garcia said. ‘But currently we know very few tumor antigens … |
|
Immunotherapy targets identified using new technology
Scope (blog) ‘The whole foundation of immunotherapy depends on immune cells recognizing specific antigens on tumor cells. That’s the basis of the actual killing event — where the rubber hits the road,’ Garcia said. ‘But currently we know very few tumor antigens … |